Point-of-care diagnosis of tuberculosis: past, present and future (Q27004667)

MORTEN RUHWALD

2

1 reference

GRANT THERON

3

1 reference

JONATHAN PETER

4

1 reference

WING CHEONG YAM

5

1 reference

language of work or name

1 reference

February 2013

1 reference

1 reference

18

1 reference

PubMed

issue

2

1 reference

PubMed

page(s)

217-32

1 reference

The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Extensively drug-resistant tuberculosis: epidemiology and management challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Tuberculosis and human immunodeficiency virus infection in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Comparative cost and performance of light-emitting diode microscopy in HIV-tuberculosis-co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Reducing the global burden of tuberculosis: the contribution of improved diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Front-loading sputum microscopy services: an opportunity to optimise smear-based case detection of tuberculosis in high prevalence countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid molecular detection of tuberculosis and rifampin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

GenoType MTBDRsl performance on clinical samples with diverse genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Progress in serodiagnosis of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Serodiagnosis of tuberculosis: due to shift track

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Serodiagnosis efficacy and immunogenicity of the fusion protein of Mycobacterium tuberculosis composed of the 10-kilodalton culture filtrate protein, ESAT-6, and the extracellular domain fragment of PPE68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Nano/Microfluidics for diagnosis of infectious diseases in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

The immunology of tuberculosis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Multicytokine detection improves latent tuberculosis diagnosis in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Discriminating between latent and active tuberculosis with multiple biomarker responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

A simple method to quantitate IP-10 in dried blood and plasma spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

A molecular assay for sensitive detection of pathogen-specific T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Microfluidic platform for real-time signaling analysis of multiple single T cells in parallel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Simultaneous detection of cell-secreted TNF-α and IFN-γ using micropatterned aptamer-modified electrodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Worldwide emergence of extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Label-free and reagentless electrochemical detection of PCR fragments using self-assembled quinone derivative monolayer: application to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Microfluidics-based diagnostics of infectious diseases in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

A modeled structure of an aptamer-gp120 complex provides insight into the mechanism of HIV-1 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Selection and application of ssDNA aptamers to detect active TB from sputum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Developments in novel breath tests for bacterial and fungal pulmonary infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Breath biomarkers of active pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Point-of-care breath test for biomarkers of active pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates circulating in China by multilocus PCR and electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Viewpoint TB diagnostics: what does the world really need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Au-nanoprobes for detection of SNPs associated with antibiotic resistance inMycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

High-resolution melting analysis for rapid detection of linezolid resistance (mediated by G2576T mutation) in Staphylococcus epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Towards a point-of-care test for active tuberculosis: obstacles and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022

Tuberculosis Diagnosis — Time for a Game Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12022